Summerpal Kahlon

Summerpal Kahlon has a diverse and extensive work experience in the healthcare industry. Starting in 2008, Kahlon worked as an Infectious Diseases specialist at Melbourne Internal Medicine Associates, where they built an inpatient ID consulting practice and opened new satellite clinics. From 2010 to 2012, Kahlon served as the VP of Medical Affairs at McKesson Provider Technologies, focusing on optimizing the use of electronic health records and consulting with health system leaders and physicians. They then worked as the VP of Business Development at RelayHealth from 2012 to 2015.

In 2015, Kahlon joined Oracle as the Director of Care Innovation, where they focused on data aggregation, warehousing, and advanced healthcare analytics to enable precision medicine and population health. They left Oracle in 2018 and took on multiple roles at Steward Health Care, including Chief Medical Information Officer and Chief Information Officer. Kahlon also held positions at Jvion and Change Healthcare, where they worked as VP Clinical Implementation & Adoption and held various roles in value-based payments.

Currently, Kahlon is working at Edifecs as the Chief Medical Officer, starting in September 2023. Prior to this, Kahlon also had a part-time role as a Staff Physician in Infectious Diseases at Veterans Administration. Overall, Kahlon's experience encompasses clinical medicine, healthcare technology, consulting, and leadership roles across various organizations in the healthcare industry.

Summerpal Kahlon obtained an MD degree in Medicine from UAB Marnix E. Heersink School of Medicine from 1999-2003. Later, they pursued an MS degree in Healthcare Informatics from the University of Central Florida from 2011-2013. Summerpal Kahlon also holds a BA degree in Economics from Case Western Reserve University, which they completed from 1996-1999. Additionally, they have a certification in Six Sigma Yellow Belt from McKesson. No specific information regarding the month or year of obtaining the certification is provided.